Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian, fallopian tube and/or primary peritoneal cancer
Files
Publication date
2017-03-03
Authors
Hoogendam, Jacob P.
Roze, Joline F
van de Wetering, Fleur T.
Spijker, René
Verleye, Leen
Vlayen, Joan
Veldhuis, WB
Scholten, R J P M
Zweemer, Ronald
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
This is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows: To assess the diagnostic test accuracy of PET(-CT), conventional and diffusion-weighted MRI as an replacement or an add-on to abdominal CT, for predicting tumour resectability at primary debulking surgery in patients with stage III - IV epithelial ovarian, fallopian tube and/or primary peritoneal cancer. To investigate the year of study initiation, the annual surgical caseload and whether surgery is performed by a gynaecological oncologist as possible sources of heterogeneity. For further details, please see Investigations of heterogeneity.
Keywords
Taverne, General Medicine, Pharmacology (medical)
Citation
Hoogendam, J P, Roze, J F, van de Wetering, F T, Spijker, R, Verleye, L, Vlayen, J, Veldhuis, W B, Scholten, R J P M & Zweemer, RP 2017, 'Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian, fallopian tube and/or primary peritoneal cancer', Cochrane Database of Systematic Reviews , vol. 2017, no. 3, CD012567. https://doi.org/10.1002/14651858.CD012567